These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32364726)

  • 1. Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.
    Proença C; Oliveira A; Freitas M; Ribeiro D; Sousa JLC; Ramos MJ; Silva AMS; Fernandes PA; Fernandes E
    J Nat Prod; 2020 May; 83(5):1541-1552. PubMed ID: 32364726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel allosteric site and covalent inhibitors of FBPase with potent hypoglycemic effects.
    Huang Y; Wei L; Han X; Chen H; Ren Y; Xu Y; Song R; Rao L; Su C; Peng C; Feng L; Wan J
    Eur J Med Chem; 2019 Dec; 184():111749. PubMed ID: 31589992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fructose-1,6-bisphosphatase inhibitors: A new valid approach for management of type 2 diabetes mellitus.
    Kaur R; Dahiya L; Kumar M
    Eur J Med Chem; 2017 Dec; 141():473-505. PubMed ID: 29055870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes.
    van Poelje PD; Potter SC; Erion MD
    Handb Exp Pharmacol; 2011; (203):279-301. PubMed ID: 21484576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological evaluation and SAR analysis of novel covalent inhibitors against fructose-1,6-bisphosphatase.
    Han X; Huang Y; Wei L; Chen H; Guo Y; Tang Z; Hu W; Xia Q; Wang Q; Yan J; Ren Y
    Bioorg Med Chem; 2020 Sep; 28(18):115624. PubMed ID: 32828433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of
    Zhou J; Bie J; Wang X; Liu Q; Li R; Chen H; Hu J; Cao H; Ji W; Li Y; Liu S; Shen Z; Xu B
    J Med Chem; 2020 Sep; 63(18):10307-10329. PubMed ID: 32820629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico screening of a novel scaffold for fructose-1,6-bisphosatase (FBPase) inhibitors.
    Huang Y; Chi B; Xu Y; Song R; Wei L; Rao L; Feng L; Ren Y; Wan J
    J Mol Graph Model; 2019 Jan; 86():142-148. PubMed ID: 30366190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-guided design of AMP mimics that inhibit fructose-1,6-bisphosphatase with high affinity and specificity.
    Erion MD; Dang Q; Reddy MR; Kasibhatla SR; Huang J; Lipscomb WN; van Poelje PD
    J Am Chem Soc; 2007 Dec; 129(50):15480-90. PubMed ID: 18041833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of 7-nitro-1H-indole-2-carboxylic acid derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase.
    Bie J; Liu S; Zhou J; Xu B; Shen Z
    Bioorg Med Chem; 2014 Mar; 22(6):1850-62. PubMed ID: 24530031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel indole derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase.
    Bie J; Liu S; Li Z; Mu Y; Xu B; Shen Z
    Eur J Med Chem; 2015 Jan; 90():394-405. PubMed ID: 25461330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of disulfide-derived fructose-1,6-bisphosphatase (FBPase) covalent inhibitors for the treatment of type 2 diabetes.
    Xu YX; Huang YY; Song RR; Ren YL; Chen X; Zhang C; Mao F; Li XK; Zhu J; Ni SS; Wan J; Li J
    Eur J Med Chem; 2020 Oct; 203():112500. PubMed ID: 32711108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent advance in the discovery of allosteric inhibitors binding to the AMP site of fructose-1,6-bisphosphatase].
    Li ZM; Bie JB; Song HR; Xu BL
    Yao Xue Xue Bao; 2011 Nov; 46(11):1291-300. PubMed ID: 22260018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-based designing, in silico screening, and biological evaluation of new potent fructose-1,6-bisphosphatase (FBPase) inhibitors.
    Tayyem RF; Zalloum HM; Elmaghrabi MR; Yousef AM; Mubarak MS
    Eur J Med Chem; 2012 Oct; 56():70-95. PubMed ID: 22960695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fructose-1,6-bisphosphatase Inhibitors: A Review of Recent (2000- 2017) Advances and Structure-Activity Relationship Studies.
    Singh S; Harmalkar DS; Choi Y; Lee K
    Curr Med Chem; 2019; 26(29):5542-5563. PubMed ID: 30182843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationship of non-phosphorus-based fructose-1,6-bisphosphatase inhibitors: 2,5-Diphenyl-1,3,4-oxadiazoles.
    Liao BR; He HB; Yang LL; Gao LX; Chang L; Tang J; Li JY; Li J; Yang F
    Eur J Med Chem; 2014 Aug; 83():15-25. PubMed ID: 24946215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes.
    Dang Q; Kasibhatla SR; Reddy KR; Jiang T; Reddy MR; Potter SC; Fujitaki JM; van Poelje PD; Huang J; Lipscomb WN; Erion MD
    J Am Chem Soc; 2007 Dec; 129(50):15491-502. PubMed ID: 18041834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fructose-1,6-bisphosphatase Inhibitors. 2. Design, synthesis, and structure-activity relationship of a series of phosphonic acid containing benzimidazoles that function as 5'-adenosinemonophosphate (AMP) mimics.
    Dang Q; Kasibhatla SR; Xiao W; Liu Y; Dare J; Taplin F; Reddy KR; Scarlato GR; Gibson T; van Poelje PD; Potter SC; Erion MD
    J Med Chem; 2010 Jan; 53(1):441-51. PubMed ID: 20055427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of fructose-1,6-bisphosphatase inhibitors for the treatment of type 2 diabetes.
    van Poelje PD; Dang Q; Erion MD
    Curr Opin Drug Discov Devel; 2007 Jul; 10(4):430-7. PubMed ID: 17659484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new level of regulation in gluconeogenesis: metabolic state modulates the intracellular localization of aldolase B and its interaction with liver fructose-1,6-bisphosphatase.
    Droppelmann CA; Sáez DE; Asenjo JL; Yáñez AJ; García-Rocha M; Concha II; Grez M; Guinovart JJ; Slebe JC
    Biochem J; 2015 Dec; 472(2):225-37. PubMed ID: 26417114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orally active aminopyridines as inhibitors of tetrameric fructose-1,6-bisphosphatase.
    Hebeisen P; Haap W; Kuhn B; Mohr P; Wessel HP; Zutter U; Kirchner S; Ruf A; Benz J; Joseph C; Alvarez-Sánchez R; Gubler M; Schott B; Benardeau A; Tozzo E; Kitas E
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3237-42. PubMed ID: 21550236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.